Your browser doesn't support javascript.
loading
El tiempo de doblaje de PSA como nuevo método diagnóstico y pronóstico del cáncer de próstata / PSA doubling time as a new diagnostic and prognostic method for prostate cancer
Llorente, Carlos; Morena, José Manuel de la; Álvarez Ardura, Manuel.
Affiliation
  • Llorente, Carlos; Universidad Rey Juan Carlos. Fundacion Hospital Alcorcón. Madrid. España
  • Morena, José Manuel de la; Universidad Rey Juan Carlos. Fundacion Hospital Alcorcón. Madrid. España
  • Álvarez Ardura, Manuel; Universidad Rey Juan Carlos. Fundacion Hospital Alcorcón. Madrid. España
Arch. esp. urol. (Ed. impr.) ; 59(10): 1083-1087, dic. 2006. ilus, tab
Article in Es | IBECS | ID: ibc-052234
Responsible library: ES1.1
Localization: ES1.1 - BNCS
RESUMEN
OBJETIVO: Evaluar el papel de la cinética del PSA en el diagnóstico y prosnóstico del cáncer de próstata.MÉTODOS: Revision sistemática de la literatura a través de Medline.RESULTADOS: Una cifra de PSAV 2 ng/ml/año se asocia a una mayor mortalidad por cáncer de próstata tras cirugía o radioterapia. Un PSADT10 meses tras fallo bioquímico despues cirugía situa a la recidiva local como causa más probable
ABSTRACT
OBJECTIVES: To review the value of PSA kinetics in the diagnosis and prognosis of prostate cancer.METHODS: Review of the literature through a Medline search.CONCLUSIONS: A pre-tretament PSAV value >2ng/ml/yr is a risk factor for increased mortality from prostate cancer after surgery or radiation therapy. A PSADT10 is more likely associated with local recurrence
Subject(s)
Fulltext
Add to My VHL
Print
XML
Search on Google
Full text: 1 Collection: 06-national / ES Database: IBECS Main subject: Prostatic Neoplasms / Prostate-Specific Antigen Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans / Male Language: Es Journal: Arch. esp. urol. (Ed. impr.) Year: 2006 Document type: Article
Fulltext
Add to My VHL
Print
XML
Search on Google
Full text: 1 Collection: 06-national / ES Database: IBECS Main subject: Prostatic Neoplasms / Prostate-Specific Antigen Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans / Male Language: Es Journal: Arch. esp. urol. (Ed. impr.) Year: 2006 Document type: Article